DiscoverCrossroads by AlantraRx-to-OTC Switch Challenges and Opportunities, a Conversation with Paul Wardle, Founder of Beacon Associates
Rx-to-OTC Switch Challenges and Opportunities, a Conversation with Paul Wardle, Founder of Beacon Associates

Rx-to-OTC Switch Challenges and Opportunities, a Conversation with Paul Wardle, Founder of Beacon Associates

Update: 2023-08-23
Share

Description

Paul Wardle led switches at HRA Pharma and Pfizer and worked on iconic switch brands such as Viagra, Advil, Lipitor and Opill. In light of recent Rx-to-OTC switches, Paul, who is now founder at Beacon Associates, shares his perspectives from his decade-long switch experience. In this episode, Rusty and Paul discussed the underlying impacts switch products bring to consumer adherence and utilization, as well as the switch process and the new ACNU regulation.

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Rx-to-OTC Switch Challenges and Opportunities, a Conversation with Paul Wardle, Founder of Beacon Associates

Rx-to-OTC Switch Challenges and Opportunities, a Conversation with Paul Wardle, Founder of Beacon Associates

Alantra